Compare TransMedics Group Inc (TMDX) vs Workday Inc (WDAY) Price & Performance

TransMedics Group (TMDX) trades at $88.27, down 1.9% on the day, with a bullish technical signal from moving averages but mixed earnings results. The company reported strong revenue growth to $605.49M in 2025, with a net income margin of 22.69%, though profitability is expected to moderate in 2026. Recent news highlights ongoing legal investigations into fiduciary duties alongside positive coverage of growth initiatives in kidney transplantation and European expansion.

The stock presents a growth opportunity with analyst consensus pointing to a $99.57 price target, but risks include margin pressure from heavy investments and legal uncertainties. Earnings misses in recent quarters and a projected decline in net income for 2026 warrant caution, though institutional interest remains with a bullish rating from 69% of analysts.

Workday (WDAY) trades at $186.28, down 4.86% today but has rallied 49.7% over three months on strong Q2 earnings beats and AI momentum. The stock shows bullish technical signals with support at $183 and resistance at $191. Fundamentally, revenue grew to $8.45B in 2025 with expanding margins, though valuation ratios remain elevated at P/E 37.94 and P/S 4.73. Recent news highlights Workday's eleventh consecutive leadership position in Gartner's HCM Magic Quadrant and growing AI adoption.

The outlook remains positive with analyst consensus at Buy (50.62%) and $204.52 price target, representing 9.8% upside. Key opportunities include AI-driven subscription growth and margin expansion, while risks involve competitive pressures from AI-native startups and execution challenges in sustaining profitability gains amid high valuations.